McKesson Corporation
MCK#55 of 134 by buybacksNYSE · Healthcare · Medical Distribution · USA
mckesson.comBuybacks · FY2026$4.75Blatest fiscal year
Buyback yield4.3%repurchases ÷ market cap
Dividends · FY2026$381Mdividend yield 0.3%
Shareholder yield4.7%buybacks + dividends ÷ market cap
Shares outstanding · 5 yr−21.4%119M shares (2026)
Buybacks ÷ free cash flow88%payout incl. dividends 95%
Fiscal-year detail
From the cash-flow statement as reported, in USD. Negative repurchases mean net share issuance.
| Fiscal year | Repurchases | Dividends | Free cash flow |
|---|---|---|---|
| FY2026Mar 2026 | $4.75B | $381M | $5.41B |
| FY2025Mar 2025 | $3.15B | $345M | $5.23B |
| FY2024Mar 2024 | $3.02B | $314M | $3.63B |
| FY2023Mar 2023 | $3.64B | $292M | $4.60B |
| FY2022Mar 2022 | $3.52B | $277M | $3.90B |
| FY2021Mar 2021 | $770M | $276M | $3.90B |
| FY2020Mar 2020 | $1.95B | $294M | $3.87B |
Repurchases in FY2026 were +51.0% versus the prior year.
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logisti…
- Market cap
- $109B
- P/E (trailing)
- 25.2×
- Fiscal year end
- March
- ISIN
- US58155Q1031
- Reporting currency
- USD
- Data updated
- Oct 10, 2026